Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Coya Therapeutics

Request full access

Leveraging proprietary regulatory T cells (Tregs) and exosome platforms to address neurologic and autoimmune disorders

Houston, United StatesFounded 2020Biotech & Life Sciences

About Coya Therapeutics

Coya Therapeutics is a clinical-stage biotechnology company that focuses on developing proprietary therapies aimed at enhancing the function of regulatory T cells (Tregs). These therapies are designed to address neurodegenerative, autoimmune, and metabolic diseases, which are areas with significant unmet medical needs. The company operates in the biotechnology sector, targeting healthcare providers and patients who suffer from these chronic conditions. Coya Therapeutics' business model revolves around research and development, clinical trials, and eventual commercialization of their therapeutic products. Revenue generation is anticipated through the successful approval and market launch of their therapies, as well as potential partnerships and licensing agreements with larger pharmaceutical companies.

Source: Dealroom company data

At a glance

Status
Listed
Founded
2020
Headquarters
Houston, United States
Listing
IPO 2023
Employees
17
Open positions
None listed
Dealroom signal
79.6/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

9 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
PRIVATE PLACEMENT NON VC✓Other financing Jan 2026 $11M — Greenlight Capital · Dr. Reddy’s Laboratories ↗
POST IPO EQUITY✓Other financing Oct 2025 $20M — Undisclosed ↗
Showing the latest 2 of 9 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowthEBITDAMarginProfitMarginR&D
2026 $7.9M 0% −$23M -283.5% −$21M -267.1% $19M
2025 $7.9M +123.6% −$23M -283.5% −$21M -267.1% $19M
2024 $3.6M -40.8% −$17M -484.6% −$15M -418.7% $12M
2023 $6M — −$6.8M -113.1% $5.5M
2022 $0 — −$9.8M — —
2021 — — −$4.9M — —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Coya Therapeutics website traffic

Latest recorded traffic for Coya Therapeutics is 9K monthly website visits, up 172.7% over the last three months. Coya Therapeutics's team grew 13.3% over the past year.

Latest monthly visits9K 3-month web change+172.7% 1-year team growth+13.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Coya Therapeutics in the Houston ecosystem

Live from Dealroom

The Coya Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Allele Capital Partners

Series B and later1 investor entered at this stage

  • Alzheimer's Drug Discovery Foundation

Other known investors5 additional known investors

  • Dr. Reddy’s Laboratories
  • Greenlight Capital
  • Houston Methodist
  • Checkmate Capital
  • Checkmate Capital Group
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Coya Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Coya Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.